StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) bonds

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.78+0.02 (+2.36%)

Close on Nov 18, 2026Market cap $35.02MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$56.08M
Long-term debt
Net debt
$25.66M
After $30.42M of cash
Implied interest rate
10.84%
FY2025 interest ÷ average debt
Interest coverage
-6.4×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in TELA Bio's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issued
MidCap term loan6.25%$40.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailableExpires
Perceptive term loan$70.00M$10.00MNov 14, 2030

See a number that looks wrong?